OCDX — ORTHO CLINICAL DIAGNOSTICS H
What is a 13F filing? Who files one and when · What 13F filings can't tell you
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
OCDX (ORTHO CLINICAL DIAGNOSTICS H) is tracked on HoldingsHub across five years of quarterly 13F filings. 38 funds have reported positions historically, with the sum of their latest reported stakes valued at $1.17B. No fund in our coverage reported a position in the latest filing period, which typically means the stock has fallen out of the tracked funds' portfolios rather than that it cannot be bought.
Major shareholders of ORTHO CLINICAL DIAGNOSTICS H (OCDX) include T. Rowe Price Associates, Vanguard Group, JPMorgan Chase & Co, ranked by reported 13F value among the 38 institutional holders on this page.
All figures on this page are computed from SEC Form 13F quarterly filings. 13F filers disclose long positions of $100,000 or more within 45 days of quarter end; short positions, options overlays and intra-quarter trades are not included, so treat the numbers as a quarterly snapshot of institutional ownership rather than real-time positioning.
Institutional Ownership by Quarter
| Quarter | Funds holding | Shares | Value | QoQ Net Change |
|---|---|---|---|---|
| Q1 2022 | 34 | 60.97M | $1.14B | +2.1% |
| Q4 2021 | 35 | 60.46M | $1.29B | -0.6% |
| Q3 2021 | 31 | 60.69M | $1.12B | +21.1% |
| Q2 2021 | 9 | 18.36M | $393.01M | +2.2% |
| Q1 2021 | 7 | 11.52M | $222.26M | — |
Over the 5 quarters shown, institutional share counts increased 429% in aggregate (Q1 2021 → Q1 2022); the largest single-quarter swing was Q3 2021 (+21.1%).
Top Institutional Holders (Q1 2022) — 25 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 19.49M | $363.67M | 0.04% | Reduce | |
| 11.05M | $206.14M | 0.01% | Hold | |
| 8.54M | $159.41M | 0.04% | Add | |
| 4.48M | $83.53M | 0.04% | Reduce | |
| 3.33M | $62.05M | 0.08% | Reduce | |
| 2.19M | $40.89M | 0.01% | Add | |
| 2.14M | $39.93M | 0.01% | Reduce | |
| 1.63M | $30.48M | 0.01% | Add | |
| 1.13M | $21.11M | 0.07% | Reduce | |
| 1.09M | $20.41M | 0.00% | Reduce | |
| 888.45K | $16.58M | 0.01% | Add | |
| 887.57K | $16.56M | 0.01% | Add | |
| 518.27K | $9.67M | 0.01% | Add | |
| 493.45K | $9.21M | 0.00% | Add | |
| 426.88K | $7.97M | 0.00% | Add | |
| 400.00K | $7.46M | 0.04% | Add | |
| 333.61K | $6.22M | 0.01% | Add | |
| 306.60K | $5.72M | 0.01% | Add | |
| 259.45K | $4.84M | 0.00% | Add | |
| 226.81K | $4.23M | 0.00% | Add | |
| 224.24K | $4.18M | 0.00% | Add | |
| 177.66K | $3.32M | 0.00% | Reduce | |
| 148.01K | $2.76M | 0.00% | Add | |
| 129.69K | $2.42M | 0.00% | Reduce | |
| 109.44K | $2.04M | 0.00% | Hold |
Holder history for earlier quarters, one table per quarter: Back to the Top 25 holders
Q4 2021 — 25 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 19.98M | $427.41M | 0.04% | Add | |
| 11.08M | $236.97M | 0.01% | Add | |
| 8.07M | $172.59M | 0.07% | Reduce | |
| 6.94M | $148.48M | 0.03% | Add | |
| 3.76M | $80.40M | 0.10% | Add | |
| 2.49M | $53.23M | 0.01% | Add | |
| 1.44M | $30.71M | 0.11% | Reduce | |
| 1.14M | $24.41M | 0.00% | Add | |
| 1.00M | $21.48M | 0.00% | Add | |
| 818.65K | $17.51M | 0.01% | Reduce | |
| 484.81K | $10.37M | 0.00% | Add | |
| 449.17K | $9.61M | 0.07% | Reduce | |
| 332.30K | $7.11M | 0.00% | Add | |
| 264.09K | $5.65M | 0.00% | Add | |
| 259.94K | $5.56M | 0.00% | Reduce | |
| 255.73K | $5.47M | 0.01% | Reduce | |
| 240.00K | $5.13M | 0.02% | Reduce | |
| 213.14K | $4.56M | 0.01% | Add | |
| 205.83K | $4.40M | 0.00% | Add | |
| 167.13K | $3.58M | 0.00% | Add | |
| 121.06K | $2.59M | 0.00% | Add | |
| 108.91K | $2.33M | 0.00% | Add | |
| 108.22K | $2.31M | 0.00% | Reduce | |
| 100.90K | $2.16M | 0.00% | Add | |
| 88.13K | $1.89M | 0.00% | Add |
Q3 2021 — 25 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 19.87M | $367.12M | 0.04% | New | |
| 10.98M | $202.91M | 0.01% | Add | |
| 8.24M | $152.24M | 0.07% | Add | |
| 5.59M | $103.29M | 0.02% | New | |
| 3.44M | $63.56M | 0.08% | New | |
| 2.47M | $45.61M | 0.01% | New | |
| 2.28M | $42.15M | 0.18% | New | |
| 1.08M | $20.04M | 0.00% | Add | |
| 1.03M | $19.02M | 0.01% | New | |
| 893.80K | $16.52M | 0.01% | New | |
| 754.67K | $13.95M | 0.07% | Add | |
| 702.87K | $12.99M | 0.10% | New | |
| 562.49K | $10.39M | 0.01% | New | |
| 417.98K | $7.72M | 0.00% | New | |
| 353.71K | $6.54M | 0.00% | New | |
| 327.25K | $6.05M | 0.00% | New | |
| 286.85K | $5.30M | 0.01% | New | |
| 244.59K | $4.52M | 0.00% | New | |
| 218.39K | $4.04M | 0.00% | New | |
| 205.91K | $3.81M | 0.00% | New | |
| 169.33K | $3.13M | 0.00% | Reduce | |
| 162.92K | $3.01M | 0.00% | New | |
| 117.42K | $2.17M | 0.00% | New | |
| 85.36K | $1.58M | 0.00% | Add | |
| 54.75K | $1.01M | 0.00% | New |
Q2 2021 — 9 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 7.83M | $167.69M | 0.00% | Add | |
| 6.36M | $136.27M | 0.06% | New | |
| 1.48M | $31.72M | 0.01% | Add | |
| 933.28K | $19.98M | 0.00% | Add | |
| 723.75K | $15.50M | 0.08% | Add | |
| 707.75K | $15.14M | 0.18% | Reduce | |
| 224.30K | $4.80M | 0.01% | New | |
| 53.17K | $1.14M | 0.00% | Add | |
| 36.30K | $777.00K | 0.00% | Add |
Q1 2021 — 7 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 7.60M | $146.64M | 0.00% | New | |
| 1.35M | $26.06M | 0.01% | New | |
| 1.12M | $21.69M | 0.36% | New | |
| 925.22K | $17.85M | 0.00% | New | |
| 486.70K | $9.39M | 0.05% | New | |
| 23.10K | $446.00K | 0.00% | New | |
| 9.10K | $176.00K | 0.00% | New |
New Positions (latest)
No fund opened a new position this quarter.
Fully Exited (vs previous quarter)
No tracked fund fully exited this quarter.
Fund Position History — shares by quarter (top 20 funds)
| Fund | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
|---|---|---|---|---|---|
| T. Rowe Price Associates | 19.49M | 19.98M | 19.87M | — | — |
| Vanguard Group | 11.05M | 11.08M | 10.98M | 7.83M | 7.60M |
| JPMorgan Chase & Co | 8.54M | 6.94M | 5.59M | — | — |
| Janus Henderson Group | 4.48M | 8.07M | 8.24M | 6.36M | — |
| Lazard Asset Management | 3.33M | 3.76M | 3.44M | — | — |
| Goldman Sachs Group | 2.19M | 1.00M | 327.25K | — | — |
| Geode Capital Management | 2.14M | 2.49M | 2.47M | — | — |
| Deutsche Bank AG | 1.63M | 332.30K | 218.39K | — | — |
| Balyasny Asset Management | 1.13M | 1.44M | 2.28M | — | — |
| Northern Trust Corp | 1.09M | 1.14M | 1.08M | 933.28K | 925.22K |
| Charles Schwab Investment Management | 888.45K | 818.65K | 893.80K | — | — |
| Citigroup Inc | 887.57K | 43.58K | 20.70K | — | — |
| Millennium Management | 518.27K | 10.31K | 562.49K | — | — |
| BNY Mellon | 493.45K | 484.81K | 417.98K | — | — |
| UBS Group AG | 426.88K | 264.09K | 244.59K | — | — |
| Point72 Asset Management | 400.00K | 240.00K | 754.67K | 723.75K | 486.70K |
| Arrowstreet Capital | 333.61K | 88.13K | 17.30K | 36.30K | 23.10K |
| Renaissance Technologies | 306.60K | 100.90K | 38.30K | 224.30K | — |
| Citadel Advisors | 259.45K | 167.13K | 162.92K | — | — |
| Manulife Financial | 226.81K | 59.08K | 54.75K | — | — |
FAQ
Which funds hold OCDX?
38 funds have reported positions in OCDX across five years of 13F filings; the sum of their latest reported stakes is $1.17B.
Who are the top institutional holders of OCDX?
The largest 13F holders are T. Rowe Price Associates, Vanguard Group, JPMorgan Chase & Co, Janus Henderson Group, Lazard Asset Management; the top 25 are ranked at the top of this page.
Who are the major shareholders of ORTHO CLINICAL DIAGNOSTICS H?
The major shareholders of ORTHO CLINICAL DIAGNOSTICS H (OCDX) by reported 13F value are T. Rowe Price Associates, Vanguard Group, JPMorgan Chase & Co, Janus Henderson Group, Lazard Asset Management, among 38 institutional holders.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.